PM
50
5
GM
60
11
AFL
55
2
JBHT
35
12
EFX
54
-11
AEP
34
5
WHR
35
3
JCI
46
2
NAVI
52
2
F
47
4
MU
47
-7
CNP
49
-8
PFG
45
2
K
39
-9
PRU
45
3
AA
29
-2
SYF
64
6
THC
65
-3
XEL
55
5
EW
38
-2
PM
50
5
GM
60
11
AFL
55
2
JBHT
35
12
EFX
54
-11
AEP
34
5
WHR
35
3
JCI
46
2
NAVI
52
2
F
47
4
MU
47
-7
CNP
49
-8
PFG
45
2
K
39
-9
PRU
45
3
AA
29
-2
SYF
64
6
THC
65
-3
XEL
55
5
EW
38
-2
Financhill
Back

Smith & Nephew PLC Vs. Akari Therapeutics PLC Industry Stock Comparison

Sell
42

SNNUF
Smith & Nephew PLC

Last Price:
11.93
Seasonality Move:
3.57%
Sell
23

AKTX
Akari Therapeutics PLC

Last Price:
1.13
Seasonality Move:
-17.92%
Sell
42
Smith & Nephew PLC (SNNUF) is a Sell

Is Smith & Nephew PLC a Buy, Sell or Hold?

  • The current Smith & Nephew PLC [SNNUF] share price is $11.93. The Score for SNNUF is 42, which is 16% below its historic median score of 50, and infers higher risk than normal.
  • SNNUF is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
23
Akari Therapeutics PLC (AKTX) is a Sell

Is Akari Therapeutics PLC a Buy, Sell or Hold?

  • The current Akari Therapeutics PLC [AKTX] share price is $1.21. The Score for AKTX is 23, which is 54% below its historic median score of 50, and infers higher risk than normal.
  • AKTX is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

SNNUF Stock Price Chart

What is Smith & Nephew PLC's stock price today?

  • The Smith & Nephew PLC share price today is $11.93
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and SNNUF is experiencing slight buying pressure.

AKTX Stock Price Chart

What is Akari Therapeutics PLC's stock price today?

  • The Akari Therapeutics PLC share price today is $1.21
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and AKTX is experiencing buying pressure, which is a positive indicator for future bullish movement.

SNNUF Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.33 Sell
Relative Strength Index (14 RSI): 29.54 Sell
Chaikin Money Flow: 0 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (11.95 - 13.03) Sell
Bollinger Bands (100): (12.62 - 13.92) Sell

AKTX Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.24 Sell
Relative Strength Index (14 RSI): 29.07 Sell
Chaikin Money Flow: 6481 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (1.26 - 1.9) Sell
Bollinger Bands (100): (1.83 - 2.99) Sell

SNNUF Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 12.13 Sell
20-day SMA: 12.26 Sell
50-day SMA: 13.11 Sell
200-day SMA: 13.16 Sell
8-day EMA: 12.06 Sell
20-day EMA: 12.34 Sell
50-day EMA: 12.82 Sell
200-day EMA: 13.26 Sell

AKTX Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 1.2 Buy
20-day SMA: 1.48 Sell
50-day SMA: 1.94 Sell
200-day SMA: 3.07 Sell
8-day EMA: 1.23 Sell
20-day EMA: 1.45 Sell
50-day EMA: 1.86 Sell
200-day EMA: 3.43 Sell

Smith & Nephew PLC Earnings Growth & SNNUF Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Akari Therapeutics PLC Earnings Growth & AKTX Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.60 per share, and a decrease next year of $0.00 per share.

Smith & Nephew PLC Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Akari Therapeutics PLC Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):